MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #31, September 2019
Apotex Corp. has announced that it is voluntarily recalling all of its ranitidine drugs in the United States due to reports that some brand name and generic ranitidine medicines have been contaminated by a probable human carcinogen known as N-Nitrosodimethylamine (NDMA).
The Ohio federal judge overseeing the federal opioid multidistrict litigation has refused to disqualify himself, rejecting defendants’ arguments that his active participation in encouraging settlement talks is evidence that he is biased against them.
A police officer has sued six distributors of a Chinese-made vaping pen in Washington state court, alleging his use of the product caused him to develop lipoid pneumonia.
A Florida federal judge has dismissed the claims of 149 Abilify plaintiffs with prejudice on the basis that they failed to comply with orders regarding a global settlement of all cases pending on the federal multidistrict litigation docket.
Sandoz Inc. has announced that it is voluntarily recalling all of its ranitidine drugs in the United States due to contamination by a probable human carcinogen known as N-Nitrosodimethylamine (NDMA), according to a MedWatch Safety Alert.
A Florida woman has sued Sanofi-Aventis in federal court, alleging her long-term ingestion of the heartburn drug Zantac (ranitidine) caused her breast cancer because it was contaminated with a probable human carcinogen.
A Florida man has sued the maker of Zantac in Florida state court, alleging it concealed the fact that its acid reflux drug Zantac (ranitidine) contained “incredibly high levels” of a probable human carcinogen.
Purdue Pharma L.P., maker of the addictive painkiller OxyCotin, has filed a voluntary petition for Chapter 11 bankruptcy in New York federal court following its agreement to settle thousands of lawsuits accusing it of perpetuating the opioid epidemic.
An 18-year-old woman has sued the makers of JUUL e-cigarettes in New York federal court, alleging she developed a severe and debilitating nicotine addiction due to defendants’ aggressive advertising tactics aimed at a youth-oriented market.
The Food and Drug Administration has issued a warning letter to JUUL Labs Inc., accusing it of marketing unauthorized modified risk tobacco products to consumers, including youths in schools, touting the products as “much safer than cigarettes.”